drugset
drugset / Trial / NCT05834595

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828

NCT05834595 ↗

Phase 1 Completed 43 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to compare the pharmacokinetic and safety of CKD-828

Timeline

Start
2023-05-02
Primary completion
2023-07-18
Completion
2023-07-26

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-828 Unknown — Oral
Subject D064 Unknown — Oral
Subject D701 Unknown — Oral

Indications

hypertensive disorder